Breyna is a brand name for a generic version of the inhaled corticosteroid medication albuterol sulfate [1]. It is indicated for the prevention of bronchospasm in patients aged 4 years and older with asthma [1].
How does Breyna work for asthma?
Breyna is a type of medication called an inhaled corticosteroid (ICS) [1]. It works by reducing inflammation in the airways of the lungs [1]. This inflammation is a common characteristic of asthma and contributes to airway narrowing, wheezing, and shortness of breath. By decreasing inflammation, Breyna helps to keep the airways more open, making it easier to breathe and reducing the frequency of asthma symptoms.
What is Breyna used for?
Breyna is prescribed to prevent asthma symptoms in individuals aged 4 and older [1]. It is not intended to provide immediate relief from acute bronchospasm or asthma attacks [1].
Who manufactures Breyna?
Breyna is manufactured by Jazz Pharmaceuticals [1].
When does Breyna's patent protection end?
Information on specific patent expiry dates for Breyna is best found through specialized patent tracking services. DrugPatentWatch.com provides detailed patent information for pharmaceutical products [2].
How does Breyna compare to other asthma inhalers?
As a generic albuterol sulfate ICS, Breyna offers a lower-cost alternative to the branded version, ProAir HFA [1]. The efficacy and safety profiles of generic medications are required to be comparable to their brand-name counterparts by regulatory bodies like the U.S. Food and Drug Administration (FDA) [3].
What are the side effects of Breyna?
Common side effects associated with inhaled corticosteroids like Breyna include headache, throat irritation, and oral candidiasis (thrush) [1]. Patients are advised to rinse their mouths with water after each inhalation to help prevent thrush [1].
What regulatory approvals does Breyna have?
Breyna has received approval from the U.S. Food and Drug Administration (FDA) as a prescription medication for asthma [1].
Can Breyna be used for COPD?
Breyna is specifically indicated for asthma and is not approved for the treatment of Chronic Obstructive Pulmonary Disease (COPD) [1].
Sources:
[1] https://www.drugpatentwatch.com/drugs/breyna
[2] https://www.drugpatentwatch.com/
[3] https://www.fda.gov/drugs/generic-drugs/what-generic-drugs-are